{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:38:07Z","timestamp":1787161087755,"version":"build-2736575974"},"reference-count":37,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,4,27]],"date-time":"2008-04-27T00:00:00Z","timestamp":1209254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background<\/jats:bold>\n                    Cluster immunotherapy is becoming increasingly used. It allows for a rapid build up phase and the administration of higher doses of allergen in a shorter period of time.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objectives<\/jats:bold>\n                    To evaluate the effect of short\u2010term pre\u2010seasonal immunotherapy using a glutaraldeyde\u2010modified allergen vaccine in reducing specific nasal hyperreactivity in nasal challenge tests.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Materials and Methods<\/jats:bold>\n                    Thirty\u2010three patients were selected. All patients had a positive history of allergic rhinitis and skin tests to grass pollen, although most of them (72.7%) were sensitized to other allergens as well. The study was conducted outside of the pollen season and the patients did not receive any pharmacological treatment during this period of time. Two randomized groups of patients were established; Group A: 22 patients (13 females and nine males) and Group B, 11 control patients (seven females and four males). Patients in Group A received immunotherapy with a vaccine containing 50% of the wild grasses\n                    <jats:italic>Trisetum paniceum<\/jats:italic>\n                    and\n                    <jats:italic>Dactylis glomerata<\/jats:italic>\n                    . All patients underwent titrated nasal provocation tests (NPT) before and after completion of the study (2.3 and 2.8 months for Groups A and B, respectively). The administration schedule consisted of 0.1 and 0.2\u2003mL at day 1, followed by 0.3 and 0.5\u2003mL at day 7, 0.5\u2003mL after 2 weeks followed by 0.5\u2003mL monthly. A single vial was used containing an allergen concentration of 10\u2003000\u2003TU\/mL (105\u2003\u03bcg of total protein and 24.6\u2003\u03bcg of Group 1 plus 5 allergens\/mL). A mean of 6.5 injections were administered to Group A patients between NPTs.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    There were no significant differences between both groups at the beginning of the study (\n                    <jats:italic>P<\/jats:italic>\n                    =0.48). At the end, only Group A patients needed significant greater threshold concentrations for a positive NPT than at the beginning (\n                    <jats:italic>P<\/jats:italic>\n                    =0.002).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions<\/jats:bold>\n                    A short\u2010term cluster pre\u2010seasonal inmunotherapy with a modified vaccine containing a mixture of grass pollen is effective as determined by an objective measure after only a mean 2.3 months of treatment.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2222.2008.02995.x","type":"journal-article","created":{"date-parts":[[2008,4,27]],"date-time":"2008-04-27T21:59:34Z","timestamp":1209333574000},"page":"987-994","source":"Crossref","is-referenced-by-count":23,"title":["Cluster immunotherapy with a glutaraldehyde\u2010modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment"],"prefix":"10.1111","volume":"38","author":[{"given":"J.","family":"Subiza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Feli\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Subiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Uhlig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fern\u00e1ndez\u2010Caldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,4,27]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"1","article-title":"WHO position paper. Allergen immunotherapy","volume":"53","author":"Bousquet J","year":"1998","journal-title":"therapeutic vaccines for allergic diseases"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001936.pub2"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(81)90200-1"},{"key":"e_1_2_5_5_2","first-page":"23","article-title":"Short\u2010term immunotherapy","volume":"100","author":"Zenner HP","year":"1997","journal-title":"a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2005.07.020"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1998.tb03969.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000086333"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2005.02343.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00790.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1992.tb02054.x"},{"key":"e_1_2_5_12_2","first-page":"430","article-title":"Hyposensitization in pollinosis. Results of a 3\u2010year controlled study with 2 depot\u2010allergoid grass pollen extracts","volume":"79","author":"Muhlethaler K","year":"1990","journal-title":"aluminum hydroxide-adsorbed allergoid and tyrosine-adsorbed allergoid"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(90)90160-6"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(89)90369-2"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(88)90017-6"},{"key":"e_1_2_5_16_2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1159\/000234277","article-title":"Double\u2010blind, placebo\u2010controlled immunotherapy with a high\u2010molecular\u2010weight, formalinized allergoid in grass pollen allergy","volume":"82","author":"Bousquet J","year":"1987","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2006.00442.x"},{"key":"e_1_2_5_18_2","first-page":"77","article-title":"Single\u2010course specific immunotherapy with mixed pollen allergoids","volume":"31","author":"Drachenberg KJ","year":"2003","journal-title":"results of a multi-centre study"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1034409"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(83)90580-8"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(86)90269-1"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(95)70028-5"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000059402"},{"key":"e_1_2_5_24_2","unstructured":"http:\/\/www.botanikus.de\/Botanik3\/Ordnung\/Goldhafer\/goldhafer.html"},{"key":"e_1_2_5_25_2","first-page":"113","article-title":"The major grass pollen group 5 allergen from Dactylis glomerata and its C\u2010terminal split product both behave as dimers","volume":"136","author":"Van Oort E","year":"2005","journal-title":"implications for allergen standardization"},{"key":"e_1_2_5_26_2","first-page":"1442","article-title":"Characterization of allergens from Trisetum paniceum pollen","volume":"27","author":"Montero MT","year":"1997","journal-title":"an important aeroallergen in Mediterranean continental climatic areas"},{"issue":"10","key":"e_1_2_5_27_2","first-page":"1","article-title":"Skin test use in Type I allergy testing. Position Paper","volume":"44","author":"Dreborg S.","year":"1989","journal-title":"Allergy"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(98)00191-4"},{"key":"e_1_2_5_29_2","volume-title":"Allergen Products (1997:1063)","author":"Council of Europe. European Pharmacopeia","year":"1997"},{"issue":"14","key":"e_1_2_5_30_2","first-page":"7","article-title":"Position paper: Immunotherapy (EAACI) The European Academy of Allergology and Clinical Immunology","volume":"48","author":"Immunotherapy Subcommittee of EAACI","year":"1993","journal-title":"Allergy"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70174-0"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.118891"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701303360502"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2006.21.6.1012"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60718-1"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112233"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1999.00651.x"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0105-4538.2001.00001.x-i9"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2008.02995.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2008.02995.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T17:42:30Z","timestamp":1697218950000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2008.02995.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,27]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1111\/j.1365-2222.2008.02995.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2008.02995.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,27]]}}}